Posted inBiotechnology
Posted inBiotechnology
Investor pumps $3M into cash-strapped Cyclacel in return for CEO role
Investor David Lazar has come to the rescue of cash-strapped Cyclacel Pharmaceuticals, pumping $3 million into the biotech as well…






















